Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled nitric oxide to reduce myocardial infarction size after primary PCI
2007-002931-95Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Nov 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nitric oxide in myocardial infarction (MI), sponsored by UZ Leuven. Started Nov 2007; status: completed.
02
Drugs
nitric oxide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2007-002931-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002931-95.